Literature DB >> 22924752

Molecular determinants of A2AR-D2R allosterism: role of the intracellular loop 3 of the D2R.

Víctor Fernández-Dueñas1, Maricel Gómez-Soler, Kenneth A Jacobson, Santhosh T Kumar, Kjell Fuxe, Dasiel O Borroto-Escuela, Francisco Ciruela.   

Abstract

In the CNS, an antagonistic interaction has been shown between adenosine A(2A) and dopamine D(2) receptors (A(2A)Rs and D(2)Rs) that may be relevant both in normal and pathological conditions (i.e., Parkinson's disease). Thus, the molecular determinants mediating this receptor-receptor interaction have recently been explored, as the fine tuning of this target (namely the A(2A)R/D(2)R oligomer) could possibly improve the treatment of certain CNS diseases. Here, we used a fluorescence resonance energy transfer-based approach to examine the allosteric modulation of the D(2)R within the A(2A)R/D(2)R oligomer and the dependence of this receptor-receptor interaction on two regions rich in positive charges on intracellular loop 3 of the D(2)R. Interestingly, we observed a negative allosteric effect of the D(2)R agonist quinpirole on A(2A)R ligand binding and activation. However, these allosteric effects were abolished upon mutation of specific arginine residues (217-222 and 267-269) on intracellular loop 3 of the D(2)R, thus demonstrating a major role of these positively charged residues in mediating the observed receptor-receptor interaction. Overall, these results provide structural insights to better understand the functioning of the A(2A)R/D(2)R oligomer in living cells.
© 2012 The Authors Journal of Neurochemistry © 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22924752      PMCID: PMC3480334          DOI: 10.1111/j.1471-4159.2012.07956.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  31 in total

Review 1.  Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease.

Authors:  K Fuxe; L F Agnati; K Jacobsen; J Hillion; M Canals; M Torvinen; B Tinner-Staines; W Staines; D Rosin; A Terasmaa; P Popoli; G Leo; V Vergoni; C Lluis; F Ciruela; R Franco; S Ferré
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

2.  Metabotropic glutamate type 1alpha receptor localizes in low-density caveolin-rich plasma membrane fractions.

Authors:  Javier Burgueño; Carlos Enrich; Enric I Canela; Josefa Mallol; Carmen Lluis; Rafael Franco; Francisco Ciruela
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

3.  Mutual regulation between metabotropic glutamate type 1alpha receptor and caveolin proteins: from traffick to constitutive activity.

Authors:  Javier Burgueño; Enric I Canela; Josefa Mallol; Carmen Lluis; Rafael Franco; Francisco Ciruela
Journal:  Exp Cell Res       Date:  2004-10-15       Impact factor: 3.905

4.  Maintenance of cellular levels of G-proteins: different efficiencies of alpha s and alpha o synthesis in GH3 cells.

Authors:  Y Li; U Mende; C Lewis; E J Neer
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

5.  Differential internalisation of mGluR1 splice variants in response to agonist and phorbol esters in permanently transfected BHK cells.

Authors:  F Ciruela; R A McIlhinney
Journal:  FEBS Lett       Date:  1997-11-24       Impact factor: 4.124

6.  Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors.

Authors:  P Svenningsson; M Lindskog; C Ledent; M Parmentier; P Greengard; B B Fredholm; G Fisone
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  A new D₂ dopamine receptor agonist allosterically modulates A(2A) adenosine receptor signalling by interacting with the A(2A)/D₂ receptor heteromer.

Authors:  Maria Letizia Trincavelli; Simona Daniele; Elisabetta Orlandini; Gemma Navarro; Vicent Casadó; Chiara Giacomelli; Susanna Nencetti; Elisa Nuti; Marco Macchia; Harald Huebner; Peter Gmeiner; Armando Rossello; Carmen Lluís; Claudia Martini
Journal:  Cell Signal       Date:  2011-12-30       Impact factor: 4.315

8.  Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors.

Authors:  Francisco Ciruela; Javier Burgueño; Vicent Casadó; Meritxell Canals; Daniel Marcellino; Steven R Goldberg; Michael Bader; Kjell Fuxe; Luigi F Agnati; Carmen Lluis; Rafael Franco; Sergi Ferré; Amina S Woods
Journal:  Anal Chem       Date:  2004-09-15       Impact factor: 6.986

9.  Oligomerization of adenosine A2A and dopamine D2 receptors in living cells.

Authors:  Toshio Kamiya; Osamu Saitoh; Kazuaki Yoshioka; Hiroyasu Nakata
Journal:  Biochem Biophys Res Commun       Date:  2003-06-27       Impact factor: 3.575

10.  Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer.

Authors:  Meritxell Canals; Daniel Marcellino; Francesca Fanelli; Francisco Ciruela; Piero de Benedetti; Steven R Goldberg; Kim Neve; Kjell Fuxe; Luigi F Agnati; Amina S Woods; Sergi Ferré; Carme Lluis; Michel Bouvier; Rafael Franco
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

View more
  23 in total

Review 1.  Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field.

Authors:  Kjell Fuxe; Dasiel O Borroto-Escuela; Wilber Romero-Fernandez; Miklós Palkovits; Alexander O Tarakanov; Francisco Ciruela; Luigi F Agnati
Journal:  Neuropsychopharmacology       Date:  2013-09-06       Impact factor: 7.853

Review 2.  Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands.

Authors:  Francisco Ciruela; Víctor Fernández-Dueñas; Kenneth A Jacobson
Journal:  Neuropharmacology       Date:  2015-04-16       Impact factor: 5.250

Review 3.  Purinergic GPCR transmembrane residues involved in ligand recognition and dimerization.

Authors:  Veronica Salmaso; Shanu Jain; Kenneth A Jacobson
Journal:  Methods Cell Biol       Date:  2021-07-12       Impact factor: 1.829

4.  Dopamine D(2) receptor-mediated modulation of adenosine A(2A) receptor agonist binding within the A(2A)R/D(2)R oligomer framework.

Authors:  Víctor Fernández-Dueñas; Maricel Gómez-Soler; Xavier Morató; Fabiana Núñez; Arijit Das; T Santhosh Kumar; Serge Jaumà; Kenneth A Jacobson; Francisco Ciruela
Journal:  Neurochem Int       Date:  2013-04-23       Impact factor: 3.921

Review 5.  Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.

Authors:  Kenneth A Jacobson
Journal:  J Med Chem       Date:  2013-05-09       Impact factor: 7.446

Review 6.  New paradigms in GPCR drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

7.  Application of BRET to monitor ligand binding to GPCRs.

Authors:  Stephen J Hill; Kevin D G Pfleger; Leigh A Stoddart; Elizabeth K M Johnstone; Amanda J Wheal; Joëlle Goulding; Matthew B Robers; Thomas Machleidt; Keith V Wood
Journal:  Nat Methods       Date:  2015-06-01       Impact factor: 28.547

Review 8.  Diversity and Bias through Receptor-Receptor Interactions in GPCR Heteroreceptor Complexes. Focus on Examples from Dopamine D2 Receptor Heteromerization.

Authors:  Kjell Fuxe; Alexander Tarakanov; Wilber Romero Fernandez; Luca Ferraro; Sergio Tanganelli; Malgorzata Filip; Luigi F Agnati; Pere Garriga; Zaida Diaz-Cabiale; Dasiel O Borroto-Escuela
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-13       Impact factor: 5.555

9.  Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats.

Authors:  Víctor Fernández-Dueñas; Jaume J Taura; Martin Cottet; Maricel Gómez-Soler; Marc López-Cano; Catherine Ledent; Masahiko Watanabe; Eric Trinquet; Jean-Philippe Pin; Rafael Luján; Thierry Durroux; Francisco Ciruela
Journal:  Dis Model Mech       Date:  2014-11-14       Impact factor: 5.758

10.  Crystal structures of the A2A adenosine receptor and their use in medicinal chemistry.

Authors:  Kenneth A Jacobson
Journal:  In Silico Pharmacol       Date:  2013-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.